Rare genetic hyperkinetic movement disorder

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Rare genetic hyperkinetic movement disorder.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

Methylphenidate hydrochloride CD

UCB

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

LISDEXAMFETAMINE DIMESYLATE

(LISDEXAMFETAMINE DIMESYLATE)standard

Camber Pharmaceuticals, Inc.

12.1 Mechanism of Action Lisdexamfetamine is a prodrug of dextroamphetamine. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimul...

FDA label ↗

METHYLPHENIDATE HYDROCHLORIDE

(METHYLPHENIDATE HYDROCHLORIDE)standard

Granules Pharmaceuticals Inc.

12.1 Mechanism of Action Methylphenidate hydrochloride is a central nervous system (CNS) stimulant. The mode of therapeutic action in ADHD is not know...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare genetic hyperkinetic movement disorder.
Search all trials →
Search clinical trials for Rare genetic hyperkinetic movement disorder

Recent News & Research

No recent news articles indexed yet for Rare genetic hyperkinetic movement disorder.
Search PubMed for Rare genetic hyperkinetic movement disorder

Browse all Rare genetic hyperkinetic movement disorder news →

Specialist Network

Top 1 by expertise

View all Rare genetic hyperkinetic movement disorder specialists →

Quick Actions